Mathew Ingham, MD
Division of Hematology/Oncology
Dr. Ingham is Assistant Professor of Medicine in the Division of Hematology and Oncology at New York Presbyterian Hospital/Columbia University Medical Center. He received his medical degree from the University of Massachusetts Medical School and completed internship and residency training in Internal Medicine at New York University Medical Center, where he served as Chief Resident. He then completed fellowship training in Hematology and Medical Oncology at New York Presbyterian Hospital/Columbia University Medical Center where he served as Chief Fellow.
Dr. Ingham specializes in the care of patients with sarcoma and gastrointestinal cancers and is also an active member of the experimental therapeutics unit. His research focuses on the development and clinical evaluation of novel targeted and immune-based therapies for the treatment of patients with sarcoma. He is the author of two recent authoritative reviews on the treatment of sarcoma published in the Journal of Clinical Oncology. He has presented his work at the American Society of Clinical Oncology Annual Meeting,. He is the principal investigator for numerous phase I and II clinical trials in the sarcoma and experimental therapeutics groups. He serves on the hospital’s Data Safety and Monitoring Committee among other leadership roles.
- Experimental Therapeutics
- Bone and Soft Tissue Tumors
- Gastrointestinal Malignancies